Atlas Trials

Study to Evaluate the Efficacy and Safety of Dronabinol Metered Dose Inhaler (MDI) in Acute Treatment of Migraine Headache

Clinical trial NCT00123201 · COMPLETED

Trial details

NCT number
NCT00123201
Sponsor
Solvay Pharmaceuticals
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Migraine With AuraMigraine Without Aura
Start date
2005-09-01
Primary completion
2007-03-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.